Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
Atopic dermatitis is a chronic inflammatory skin disease that may require systemic therapy. Ciclosporin A (CsA) is a widely used, potent immunosuppressant but it is not effective in all patients with atopic dermatitis, and side‐effects limit its use. Dupilumab, a fully human anti‐interleukin 4 recep...
Gardado en:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | inglés |
| Publicado: |
2017
|
| Acceso en liña: | https://doi.org/10.1111/bjd.16156 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.16156 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|